RGEN Repligen Corp

Repligen Corp is a bioprocessing company developing, producing and commercializing biologic drugs. The company offers its products to life science companies, global biopharmaceutical companies, and contract manufacturers worldwide.

$172.40  +0.80 (0.46%)
As of 05/13/2021 10:21:01 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Medical Instruments & Supplies
Index country:  USA
Country of incorporation:  USA
IPO date:  03/05/2001
Outstanding shares:  54,904,466
Average volume:  337,803
Market cap:   $9,615,419,131
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    759916109
ISIN:        US7599161095
Sedol:      2731654
Valuation   (See tab for details)
PE ratio:   121.08
PB ratio:   6.19
PS ratio:   22.21
Return on equity:   5.11%
Net income %:   18.37%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy